FDA
Stavudine; Lamivudine; Nevirapine
The FDA lists this product in 6 strengths and forms.
Composition
- Active ingredients
- STAVUDINE 30MG; LAMIVUDINE 150MG; NEVIRAPINE 200MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- STAVUDINE 30MG; LAMIVUDINE 150MG; NEVIRAPINE 200MG · TabletNDA022177-001 · Tentative approval
- STAVUDINE 40MG; LAMIVUDINE 150MG; NEVIRAPINE 200MG · TabletNDA021837-001 · Tentative approval
- STAVUDINE 30MG; LAMIVUDINE 150MG; NEVIRAPINE 200MG · TabletThis page
- STAVUDINE 40MG; LAMIVUDINE 150MG; NEVIRAPINE 200MG · TabletNDA022342-002 · Tentative approval
- STAVUDINE 30MG; LAMIVUDINE 150MG; NEVIRAPINE 200MG · TabletNDA022346-001 · Tentative approval
- STAVUDINE 40MG; LAMIVUDINE 150MG; NEVIRAPINE 200MG · TabletNDA022346-002 · Tentative approval
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA022342.